105931-57-5Relevant articles and documents
Nucleosidic phosphoramidite synthesis via phosphitylation: Activator selection and process development
Xie, Chaoyu,Staszak, Michael A.,Quatroche, John T.,Sturgill, Christa D.,Khau, Vien V.,Martinelli, Michael J.
, p. 730 - 737 (2005)
Nucleosidic phosphoramidites are key building blocks for the automated, solid supported syntheses of oligonucleotide-based drugs. A safe, industrially viable process for preparing nucleosidic phosphoramidites 5-Me-MOE-U and MOE-A has been developed and ut
Antisense inhibition via RNAse H-independent reduction in mRNA
-
Page/Page column 17, (2010/02/12)
The present invention provides compositions and methods for reducing levels of a preselected mRNA, using antisense compounds targeted to a splice site or a region up to 50 nucleobases upstream of an exon/intron junction on said mRNA. Preferably, said antisense compounds do not elicit RNAse H cleavage of the mRNA.
Antisense modulation of sterol regulatory element-binding protein-1 expression
-
, (2008/06/13)
Antisense compounds, compositions and methods are provided for modulating the expression of sterol regulatory element-binding protein-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids enco